{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:21:44Z","timestamp":1780471304858,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.taap.2017.03.014","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T14:48:33Z","timestamp":1489589313000},"page":"53-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The effect of angiotensin receptor neprilysin inhibitor, sacubitril\/valsartan, on central nervous system amyloid-\u03b2 concentrations and clearance in the cynomolgus monkey"],"prefix":"10.1016","volume":"323","author":[{"given":"Heidi A.","family":"Schoenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Holubasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Buono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"DeCristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Douville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey G.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1553-6153","authenticated-orcid":false,"given":"Frederic","family":"Cumin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.03.014_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(01)02390-3","article-title":"Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition","volume":"902","author":"Akiyama","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2017.03.014_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.21623","article-title":"A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","volume":"66","author":"Bateman","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.taap.2017.03.014_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bj2590069","article-title":"Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid","volume":"259","author":"Bourne","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2017.03.014_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"Carson","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2017.03.014_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/13506129.2010.483119","article-title":"Distribution of neprilysin and deposit patterns of Abeta subtypes in the brains of aged squirrel monkeys (Saimiri sciureus)","volume":"17","author":"Chambers","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.taap.2017.03.014_bb0030","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1523\/JNEUROSCI.1381-10.2010","article-title":"Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound","volume":"30","author":"Cook","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2017.03.014_bb0035","first-page":"173","article-title":"Poor memory performance in aged cynomolgus monkeys with hippocampal atrophy, depletion of amyloid beta 1-42 and accumulation of tau proteins in cerebrospinal fluid","volume":"28","author":"Darusman","year":"2014","journal-title":"In Vivo"},{"key":"10.1016\/j.taap.2017.03.014_bb0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2017.03.014_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057108327328","article-title":"A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7","volume":"14","author":"Doering","year":"2009","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.taap.2017.03.014_bb0055","first-page":"1","article-title":"Disposition and metabolism of [C] sacubitril\/valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects","author":"Flarakos","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2017.03.014_bb0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jnr.490340407","article-title":"Localization of neprilysin (EC 3.4.24.11) mRNA in rat brain by in situ hybridization","volume":"34","author":"Gaudoux","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2017.03.014_bb0065","first-page":"357","article-title":"The amyloid deposits in Alzheimer's disease: their nature and pathogenesis","volume":"2","author":"Glenner","year":"1984","journal-title":"Appl. Pathol."},{"key":"10.1016\/j.taap.2017.03.014_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2015.00017","article-title":"Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease","volume":"9","author":"Gonzalez-Marrero","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.taap.2017.03.014_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14779072.2016.1128827","article-title":"Sacubitril\/valsartan (LCZ696) for the treatment of heart failure","volume":"14","author":"Gori","year":"2016","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.taap.2017.03.014_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2017.03.014_bb0085","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.taap.2017.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/138161212799315885","article-title":"Nonhuman primate models of Alzheimer-like cerebral proteopathy","volume":"18","author":"Heuer","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2017.03.014_bb0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0196-9781(95)00021-B","article-title":"Neutral endopeptidase can hydrolyze \u03b2 amyloid(1-40) but shows no effect on \u03b2-amyloid precursor protein metabolism","volume":"16","author":"Howell","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.taap.2017.03.014_bb0050","series-title":"Step 5. European Medicines Agency. EMA\/CHMP\/ICH\/1995)","article-title":"Guideline on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals","author":"ICH M3 (R2)","year":"2009"},{"key":"10.1016\/j.taap.2017.03.014_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/77399","article-title":"Identification of the major A\u03b21-42 degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2017.03.014_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2017.03.014_bb9005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","article-title":"Amyloid beta protein (A\u03b2) deposition: A\u03b242(43) precedes A\u03b240 in down syndrome","volume":"37","author":"Iwatsubo","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.taap.2017.03.014_bb0110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2017.03.014_bb0115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2017.03.014_bb0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bcp.12861","article-title":"The effect of LCZ696 on amyloid-beta concentrations in cerebrospinal fluid in healthy subjects","volume":"81","author":"Langenickel","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2017.03.014_bb0125","doi-asserted-by":"crossref","first-page":"29645","DOI":"10.1074\/jbc.R800022200","article-title":"The AbetaCs of Abeta-cleaving proteases","volume":"283","author":"Leissring","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.03.014_bb0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.taap.2017.03.014_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/bj2280487","article-title":"The metabolism of neuropeptides. Endopeptidase-24.11 in human synaptic membrane preparations hydrolyses substance P","volume":"228","author":"Matsas","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2017.03.014_bb0140","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0306-4522(86)90113-2","article-title":"An immunohistochemical study of endopeptidase-24.11 (\u201cenkephalinase\u201d) in the pig nervous system","volume":"18","author":"Matsas","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2017.03.014_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.250","article-title":"Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances","volume":"17","author":"McMurray","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.taap.2017.03.014_bb0150","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2017.03.014_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnagi.2014.00235","article-title":"Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease","volume":"6","author":"Nalivaeva","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.taap.2017.03.014_bb9500","series-title":"Guide for the care and use of laboratory animals","author":"National Research Council of the National Academies","year":"2011"},{"key":"10.1016\/j.taap.2017.03.014_bb0160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0192623311436180","article-title":"Technical guide for nervous system sampling of the cynomolgus monkey for general toxicity studies","volume":"40","author":"Pardo","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2017.03.014_bb0165","first-page":"1423","article-title":"Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease","volume":"138","author":"Podlisny","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2017.03.014_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0304-3940(87)90510-6","article-title":"Enkephalinase (EC 3.4.24.11) is highly localized to a striatonigral pathway in rat brain","volume":"77","author":"Pollard","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2017.03.014_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24270","article-title":"Amyloid-beta efflux from the central nervous system into the plasma","volume":"76","author":"Roberts","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.taap.2017.03.014_bb0180","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid beta-protein","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.taap.2017.03.014_bb7000","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.febslet.2013.12.038","article-title":"The dark sides of amyloid in Alzheimer's disease pathogenesis","volume":"588","author":"Sorrentino","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2017.03.014_bb0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/oxfordjournals.jbchem.a022839","article-title":"Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid \u03b2 peptide in the brain","volume":"128","author":"Takaki","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.taap.2017.03.014_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1354\/vp.45-4-455","article-title":"Complementary distributions of amyloid-beta and neprilysin in the brains of dogs and cats","volume":"45","author":"Takeuchi","year":"2008","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.taap.2017.03.014_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.taap.2017.03.014_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.taap.2017.03.014_bb0205","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.drudis.2006.08.004","article-title":"Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives","volume":"11","author":"Wang","year":"2006","journal-title":"Drug Discov. Today"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17301187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17301187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T10:54:34Z","timestamp":1535972074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17301187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":44,"alternative-id":["S0041008X17301187"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.03.014","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of angiotensin receptor neprilysin inhibitor, sacubitril\/valsartan, on central nervous system amyloid-\u03b2 concentrations and clearance in the cynomolgus monkey","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}